Skip to main content
. 2022 Dec 14;20(1):582–592. doi: 10.1021/acs.molpharmaceut.2c00815

Figure 4.

Figure 4

Representative T2-weighted MRI images in NRG mice with U251-Luc human GBM tumors at 28 d after CED of (A) normal saline, (B) unlabeled AuNPs (4 × 1011 AuNPs), or (C) 1.1 MBq of 177Lu-AuNPs (4 × 1011 AuNPs). Tumors in the brain in control mice are indicated by the arrows. There was no visible tumor in the brain in mice treated with 177Lu-AuNPs. (D) Tumor volume measured by analysis of MRI images. Horizontal lines indicate the mean ± SEM (n = 8–10).